Formulation and Development of Tara Gum-mediated Tablets for Delivery of Anticancer Drugs
BIO Integration · 2024 · 5 (1)
DOI: 10.15212/bioi-2024-0040 ↗Kurz gefasst
Fachartikel in der Zeitschrift BIO Integration, 2024. Verfasst von Pravinkumar Dinkar Lade und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Natural polysaccharide tara gum (TG) has been investigated for several biological uses. The current study involved the administration of imatinib, an anticancer model medication, via TG.
Methods
Imatinib-modified release tablets were developed using a direct compression method with different concentrations of TG and other excipients. Compressed tablets were evaluated for physicochemical properties.
Result
All formulations had an in vitro disintegration time ranging from 10–23 min. Among the formulations, F6 exhibited excellent extended-release behaviour with 72% release over 12 h. TG tablets were rich in phytoconstituents, including saponins, tannins, phenolics, flavonoids, carbohydrates, proteins, and amino acids.
Conclusion
TG has potential in the drug delivery application of anticancer medications as a rate-retarding polymer.
Zitieren
APA
Lade, P. D., & Singla, N. (2024). Formulation and Development of Tara Gum-mediated Tablets for Delivery of Anticancer Drugs. BIO Integration, 5(1). https://doi.org/10.15212/bioi-2024-0040
Vancouver
Lade PD, Singla N. Formulation and Development of Tara Gum-mediated Tablets for Delivery of Anticancer Drugs. BIO Integration. 2024;5(1). doi:10.15212/bioi-2024-0040
BibTeX
@article{Lade2024,
author = {Lade, Pravinkumar Dinkar and Singla, Neelam},
title = {Formulation and Development of Tara Gum-mediated Tablets for Delivery of Anticancer Drugs},
journal = {BIO Integration},
year = {2024},
volume = {5},
number = {1},
doi = {10.15212/bioi-2024-0040}
}
EUVIMED